ATE203519T1 - Chinolinderivate als antimalariamittel - Google Patents

Chinolinderivate als antimalariamittel

Info

Publication number
ATE203519T1
ATE203519T1 AT96938130T AT96938130T ATE203519T1 AT E203519 T1 ATE203519 T1 AT E203519T1 AT 96938130 T AT96938130 T AT 96938130T AT 96938130 T AT96938130 T AT 96938130T AT E203519 T1 ATE203519 T1 AT E203519T1
Authority
AT
Austria
Prior art keywords
antimalariatic
agents
quinoline derivatives
derivatives
quinoline
Prior art date
Application number
AT96938130T
Other languages
English (en)
Inventor
Werner Hofheinz
Raffaello Masciadri
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE203519T1 publication Critical patent/ATE203519T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Dental Preparations (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT96938130T 1995-11-16 1996-11-07 Chinolinderivate als antimalariamittel ATE203519T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH325095 1995-11-16
PCT/EP1996/004866 WO1997018193A1 (en) 1995-11-16 1996-11-07 Antimalarial quinolin derivatives

Publications (1)

Publication Number Publication Date
ATE203519T1 true ATE203519T1 (de) 2001-08-15

Family

ID=4251904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96938130T ATE203519T1 (de) 1995-11-16 1996-11-07 Chinolinderivate als antimalariamittel

Country Status (17)

Country Link
US (1) US5948791A (de)
EP (1) EP0876346B1 (de)
JP (1) JP3034609B2 (de)
KR (1) KR100263802B1 (de)
CN (1) CN1166639C (de)
AT (1) ATE203519T1 (de)
AU (1) AU718932B2 (de)
BR (1) BR9611727A (de)
CA (1) CA2237997A1 (de)
DE (1) DE69614149T2 (de)
DK (1) DK0876346T3 (de)
ES (1) ES2162110T3 (de)
GR (1) GR3037018T3 (de)
MX (1) MX9803827A (de)
PT (1) PT876346E (de)
TR (1) TR199800854T2 (de)
WO (1) WO1997018193A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
WO2001003649A2 (en) 1999-07-13 2001-01-18 Alpha Research Group, Llc Compositions and methods for the treatment of parkinson's disease
FR2807433B1 (fr) 2000-04-06 2002-09-20 Centre Nat Rech Scient Molecules duales contenant un derives peroxydique, leur synthese et leurs applications therapeutiques
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
US6818772B2 (en) 2002-02-22 2004-11-16 Abbott Laboratories Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
WO2003070244A1 (en) * 2002-02-22 2003-08-28 Abbott Laboratories Antagonist of melanin concentrating hormone and their uses
US20060014786A1 (en) * 2002-05-17 2006-01-19 Rajeev Raut Opthalmic pharmaceutical compositions and methods for treating ocular inflammation
US7084157B2 (en) * 2002-05-17 2006-08-01 Rajeev Raut Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation
US7108992B2 (en) * 2002-11-27 2006-09-19 St. Jude Children's Research Hospital ATM kinase compositions and methods
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
US7968539B2 (en) 2005-02-17 2011-06-28 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Portland State University Quinoline derivatives and uses thereof
US8440695B2 (en) * 2005-11-09 2013-05-14 St Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
FR2902100A1 (fr) * 2006-06-13 2007-12-14 Sanofi Aventis Sa Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique
WO2010059633A2 (en) 2008-11-18 2010-05-27 Oregon Health & Science University Compounds for treating parasitic disease
GB201206280D0 (en) * 2012-04-10 2012-05-23 Univ Dundee Anti-malarial agents
JPWO2015133280A1 (ja) * 2014-03-03 2017-04-06 公立大学法人名古屋市立大学 抗マラリア活性化合物及び抗マラリア薬
WO2022112596A1 (en) 2020-11-30 2022-06-02 Cellectis Sa Use of aminoquinoline compounds for higher gene integration
WO2022191092A1 (ja) * 2021-03-12 2022-09-15 国立大学法人東北大学 キノリン化合物、hnmt阻害剤、及びadhd、ナルコレプシー又はアルツハイマーの予防・治療剤
WO2024092255A2 (en) * 2022-10-28 2024-05-02 Handford Mason J 4-aminoquinolines for treatment of multidrug resistant malaria
WO2025244856A1 (en) * 2024-05-24 2025-11-27 Oregon Health & Science University Methods and compositions relating to elq compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2816893A (en) * 1957-12-17 Improvements in or relating to
US2901484A (en) * 1957-03-04 1959-08-25 Abbott Lab Bis-quinoliniums
US3126384A (en) * 1961-05-26 1964-03-24 X-quinolyl-aminoalkylamino
US5510356A (en) * 1991-10-03 1996-04-23 University Of Nebraska Board Of Regents Bisquinolines and processes for their production and use to treat malaria
WO1995035288A1 (en) * 1994-06-17 1995-12-28 F.Hoffmann-La Roche Ag Bisquinolines for the treatment of malaria
CA2192203A1 (en) * 1994-06-17 1995-12-28 Werner Hofheinz N,n'-bis(quinolin-4-yl)-diamine derivatives, their preparation and their use as antimalarials

Also Published As

Publication number Publication date
DK0876346T3 (da) 2001-11-12
EP0876346A1 (de) 1998-11-11
CN1202155A (zh) 1998-12-16
JP3034609B2 (ja) 2000-04-17
EP0876346B1 (de) 2001-07-25
BR9611727A (pt) 1999-05-25
KR100263802B1 (ko) 2001-01-15
DE69614149D1 (de) 2001-08-30
WO1997018193A1 (en) 1997-05-22
TR199800854T2 (xx) 1998-08-21
PT876346E (pt) 2002-01-30
JPH11500749A (ja) 1999-01-19
US5948791A (en) 1999-09-07
AU718932B2 (en) 2000-05-04
AU7566996A (en) 1997-06-05
KR19990067646A (ko) 1999-08-25
CA2237997A1 (en) 1997-05-22
CN1166639C (zh) 2004-09-15
ES2162110T3 (es) 2001-12-16
GR3037018T3 (en) 2002-01-31
DE69614149T2 (de) 2002-03-14
MX9803827A (es) 1998-09-30

Similar Documents

Publication Publication Date Title
DE69614149D1 (de) Chinolinderivate als antimalariamittel
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
HN1995009160A (es) Derivados de cicloalcano indol y azaindol
ATA204894A (de) Isochinoline
DE69925133D1 (de) Pyrrolobenzodiazepine
ES2178093T3 (es) Derivados de epotilon y su preparacion.
HN1996000082A (es) Compuestos de quinolina y quinozssolina utiles en terapia.
DE69530606D1 (de) Verwendung von pramipexole als neuroschutzmittel
ID23374A (id) Halogenopirimidin
BR9808491A (pt) Compostos calcilìticos
BR9711586A (pt) Compostos e uso dos mesmo
ATE167670T1 (de) N-alkylthiopolyaminderivate als radioprotektive mittel
DE69814894D1 (de) Isochinolin derivate als urokinase inhibitoren
PY0101314A (es) Compuestos farmaceuticos
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
NO980296D0 (no) Forbedrede terapeutiske midler
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
BG100248A (bg) Инхибитори на скваленсинтетаза
ES2192610T3 (es) Aminouracilos substituidos.
FI956150A7 (fi) Isokinoliinijohdannaisia terapeuttisina aineina
ATE204255T1 (de) Carbostyrilderivate als antithrombotische mittel
DE59608611D1 (de) Topische aciclovir-zubereitung
ATE187165T1 (de) Benzophenonhydrazon-derivate als insektizide
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee